Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Peripheral arterial disease (PAD) is a clinical manifestation of atherosclerotic disease, typically affecting the abdominal aorta, iliac arteries, and lower limbs.1 This condition is associated with a higher risk of major adverse cardiovascular events (MACE) and major adverse limb events (MALE), and is a strong predictor of both all-cause and cardiovascular mortalities.2 Additionally, hospitalizations due to PAD have led to a substantial economic burden on health care systems.3 In addition to their glucose-lowering effects, glucagon-like peptide-1 receptor agonists (GLP-1RAs) are associated with weight loss and have multiple favorable metabolic and anti-inflammatory effects.4 Due to their cardio- and nephro-protective properties, GLP-1RAs are recommended as first-line antidiabetic therapies for patients at high cardiovascular risk.5 Moreover, GLP-1RAs may improve arterial stiffness and provide systemic microcirculatory benefits in the peripheral vascular system
Beyond weight management, acetyl-L-carnitine benefits have been studied in areas such as cognitive function, cardiac function in certain clinical populations, and glucose metabolism
The results support the U.S
"As we think about investments in technology and how do we improve that experience overall, this was an area where bringing some of those capabilities a little bit more front and center with real-time tracking, shipping status, et cetera was really important," Honken said
Passive Distraction Test HERE
